The Impact of Subclinical Ketosis in Large by Ospina, Paula et al.
Prevalence of subclinical ketosis (SCK) on well-
managed TMR fed freestall herds in the Northeast 
and upper Midwest is high and costly. Current 
research shows that treating SCK cows with propyl-
ene glycol is cost-effective in almost all scenarios 
until preventive management strategies are imple-
mented.    
Although all cows visit a state of negative energy 
balance as they transition from late gestation to early 
lactation, some cows do this less smoothly, resulting 
in milk loss, disease, poorer reproduction, and even 
death or culling. Similarly, certain herds face more 
challenges when managing the transition period.  
To combat this negative energy balance cows 
supplement food eaten with fuel from body stores. 
And they break down fat to produce non-esterified 
fatty acids (NEFA), some of which are converted to 
ketones (e.g., B-hydroxybutyrate; BHB) when the 
liver is overwhelmed with NEFA.  At the herd level, 
management and nutrition should be optimized to 
meet the cow’s energy needs, minimize the length 
and depth of negative energy balance, and maintain a 
desired level of milk production.
Some amount of both NEFA and BHB are nor-
mal in early lactation ruminants, however, exces-
sive amounts of either can lead to increased risk of 
disease, decreased reproductive performance and 
decreased milk production.  Ketone monitoring and 
evaluation can be less expensive and more practical 
than NEFA monitoring, although NEFA concentra-
tions are a bit more predictive. Additionally, some 
cow-side ketone tests also offer a high degree of 
accuracy.  The most common fluids used for ketone 
tests, presented in order of increasing accuracy, are: 
urine (e.g. Ketostix®), milk (e.g. KetoTest™), and 
blood (e.g. Precision Xtra™ Meter).  The  blood 
meter, a hand-held device originally designed for use 
in humans with diabetes, costs about $30 and the test 
strips cost around $1.50 per sample when purchased 
through your veterinarian.  This test is very accurate 
(>96% sensitivity and 99% specificity) and gives a 
cow-side answer in about 10 seconds. 
To establish an objective BHB threshold which 
could be used to monitor both individual cows 
and herds for subclinical ketosis (SCK), a Cornell 
University study evaluated a sample of 100 TMR-
fed, free-stall herds located in the northeast, with 
good computer records.  Subclinical ketosis is 
defined as having an excessive BHB concentration 
that is associated with increased risk of disease, but is 
below clinical ketosis (CK) levels. In this study, the 
cut-point for SCK was identified as  1. mmol/ for 
cows 3 to14 days in milk (DIM). Cows in this range 
were 10 times more likely to develop a displaced 
abomasum (DA), andor CK, andor metritis when 
compared to cows with BHB concentration less than 
1. mmol/. These SCK positive cows were also 
twice as likely to leave the herd and produced less 
milk (a1000 lbscowlactation) than their healthy 
counterparts.  
Based on information from 60 herds in the study, 
when more than 15% (3 out of 15) of animals 
sampled from 3 to 14 DIM had BHB concentrations 
> 1. mmol/, these herds had a 1.% increased inci-
dence in DA and CK in the first 30 DIM and a 1% 
lower 1-d pregnancy risk compared to herds with 
less than 15%.  If more than 15% of cows had BHB 
concentrations above 1. mmol/, the herd ME 305 
milk average was considerably less; approximately 
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Figure 1. Prevalence of herds showing the percent of sampled animals within herd 
above BHB > 1.2 mmol/L (~12mg/dl). 40% of herds were above the herd alarm 
level of 15% of sampled animals.
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1,100 pounds less per cow.  
It is important to note that these herds were not chosen to partici-
pate in the study due to any issues with metabolic disease.  Within 
herds only cows that appeared healthy were sampled. To be included 
in the study, a cow could not have already developed a DA, CK or 
metritis.  Despite these selection criteria, the prevalence of herds 
above the herd alarm level was 40%.  Being above the herd alarm 
level means that more than 15% of sampled animals had BHB con-
centrations > 1. mmol/. 
In the study prevalence, an estimate of existing cases of dis-
ease, was used to evaluate the effect of SCK on herd performance.  
Estimating herd prevalence can be done very quickly, and it is recom-
mended to sample at least 15 to 0 healthy animals between 3 to 14 
DIM and record how many of the animals sampled have BHB con-
centrations > 1. mmol/.  For example, if 0 animals are sampled 
and 4 have a BHB concentration  1. mmol/, then the prevalence 
is 0% (40) and the herd is considered at increased risk for nega-
tive downstream outcomes.
Although prevalence is a very useful measurement, the incidence 
of a condition sometimes gives different information. Incidence is 
defined as the number of cows that develop a new case of SCK, 
divided by all the animals at risk.  If, for example, 15 cows within 
a group of 50 sampled cows develops a new case of SCK sometime 
from 3 to 16 DIM, the incidence is 30% (1550).  The incidence of 
SCK is approximately twice the prevalence.   
A more recent study by researchers at Cornell and the University 
of Wisconsin followed 1,717 cows from 3 to 16 DIM in 4 free-stall, 
TMR-fed herds. Using the Precision Xtra meter, all cows that calved 
within the study period were monitored for SCK, defined as a BHB 
concentration of 1. ± .9 mmol/. Cows were tested on Mondays, 
Wednesdays and Fridays. Each cow was sampled six times, begin-
ning at 3, 4 or 5 DIM and ending on 14, 15 or 16 DIM.  The highest 
incidence of SCK occurred at 5 DIM, with 75% of cows that devel-
oped SCK testing positive for the first time from 3 to 7 DIM. Cows 
that tested SCK positive from 3 to 7 DIM were over 6 times more 
likely to develop a DA, 4.5 times more likely to be removed from the 
herd, 0.7 times as likely to conceive to first service, and made almost 
5 pounds less milk per cow per day for the first 30 DIM than cows 
first testing SCK positive between  and 16 DIM.  Thus it is impor-
tant to identify these SCK cows early in lactation to reduce the risk 
of negative downstream events.  
The above study also looked at risk factors in dry cows to help 
predict which cows developed ketosis between 3 and 5 DIM, as most 
cows first develop SCK during this time, and are at a higher risk for 
negative events than cows that first develop SCK later in lactation.  
Cows with pre-calving NEFA  0.30 mEq/ were almost two times 
more likely to develop ketosis than cows with NEFA  0.30 mEq/. 
Similarly, cows birthing male calves were 1. times more likely to 
develop ketosis than cows birthing female calves.  In addition, cows 
with a calving ease  3 on a scale of 1 to 5 were .6 times more 
likely to develop ketosis than cows with a calving ease < 3, cows that 
gave birth to a dead calf were . times more likely to develop keto-
sis than cows that gave birth to a live calf, and parity  3 cows were 
3 times more likely to develop ketosis than their younger herdsmates. 
Thus for herd managers and owners who choose to focus their ketosis 
testing, rather than to test all fresh cows, should pay special attention 
to cows with high pre-calving NEFA, older cows and cows that have 
had difficulty birthing.
The same study evaluated the benefits of daily oral drenching of 
propylene glycol in cows diagnosed with SCK.  The first time a cow 
tested positive for SCK she was randomized to either the treatment 
group where she received 300 m/ (10 oz) of propylene glycol by 
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Figure 2. Incidence of subclinical ketosis (B-hydroxybutyrate > 1.2 mmol/L) by days in milk of test.
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oral drench once daily until she tested < 1. mmol/ or the control 
group where she was not given propylene glycol. Most cows were 
treated for 5 days. The SCK positive cows treated with propylene 
glycol were almost half as likely to develop a DA, half as likely to 
be removed from the herd, and on some farms made more milk (3 
pounds per cow per day) in early lactation than SCK cows not given 
propylene glycol. In addition, SCK cows treated with propylene gly-
col were more likely to conceive at first service. Based on this study 
and the expected duration of SCK, treatment of SCK positive cows 
with a 5 day course of daily propylene glycol drenching is suggested.  
A partial budget was developed to assess the benefit:cost ratio of 
different SCK testing scenarios and treatment with propylene glycol. 
On a herd level, the most cost-effective method depends on the herd 
SCK incidence. This analysis evaluated four different testing and 
treatment strategies at varying herd SCK incidences. Results indicate 
that at herd SCK incidences above 50%, blanket treatment of all fresh 
cows with 5 days of oral propylene glycol starting at 5 DIM is the 
most cost-effective strategy. At incidences between 15 and 50%, test-
ing cows that are 3 through 9 DIM two days per week (e.g. Mondays 
and Thursdays) and treating SCK positive cows with 5 days of oral 
propylene glycol is the most cost-effective strategy; although testing 
all cows that are 3 through 16 DIM one day per week (e.g. Mondays) 
will also provide a positive return on investment.  For a herd with a 
40% incidence of SCK that freshens 1,000 cows per year, choosing 
to test cows two days per week and treat the positives will benefit 
$10,000 to $5,000 per year.  
It may be easier to first conduct a SCK prevalence test (sample 
15 to 0 cows) on a herd to approximate the herd incidence and 
determine the best test and treatment plan.  For those herds with an 
estimated incidence greater than 50%, where blanket treatment with 
PG is initiated, repeated prevalence testing may be necessary after 
management changes to determine if treating all fresh cows remains 
the best option.  For herds with an incidence from 15 to 50%, either 
the one day per week or two day per week testing strategies will 
allow for repeated monitoring of herd incidence. It is important to 
remember that herds where cows are tested from 3 to 9 DIM should 
assume that only 0% of the cows that will develop SCK between 3 
and 16 DIM are identified. Repeated incidence or prevalence testing 
is recommended to evaluate changes in transition cow management 
and to allow appropriate adjustment of farm SCK testing and treat-
ment protocols.  Remember the goal is to not treat many, if any, cows 
with propylene glycol, but rather have transition cow management 
strategies in place to lower the prevalence of SCK to less than 15%.
SCK is a condition not recognized clinically until it predisposes 
cows and herds to higher incidences of transition cow diseases, lower 
milk production, and lower milk production. Thus it is costly. Work 
with your management team to develop a testing strategy to assess 
your level.
Feed Lower-Starch Diets to Fresh Cows?
continued from page 30
weight and body condition, and concentra-
tions of serum nonesterified fatty acids 
(NEFA) and hydroxybutyrate (BHBA). 
Serum NEFA tended to be higher for cows 
fed MH than cows fed // or HH.
This study demonstrated that lower-
starch (3%) diets can support lacta-
tional performance following a high-fiber, 
controlled-energy dry diet. Some keys to 
making lower-starch lactation diets work 
include use of high quality forages and 
nonforage fiber sources and increasing the 
sugar content. The step-up diet approach 
(MH) may be preferred over the 1-group 
lactation diet approach (// and HH) 
because of improvements in nutrient use 
(i.e. milk nitrogen efficiency). However, 
the 1-group lactation diet approach (//) 
may be preferred when energy from corn 
starch is expensive relative to energy from 
nonforage fiber sources or when a facility 
does not have the ability to have  groups 
in early lactation.
ab Least squares means within a row without a common superscript differ (P 0.05).
xy Least squares means within a row without a common superscript differ (P 0.10).
 Dietary Treatment
Item LL MH HH P - value
DMI, lb/d 55.4x 54.8xy 52.1y 0.06
Starch intake, lb/d 11.7b 13.9a 13.4a <0.01
Rumen fermentable starch, lb/d 9.7b 11.4a 11.0a <0.01
Neutral detergent ﬁber intake, lb/d 19.8a 17.8b 16.7b <0.01
Milk, lb/d 105.4ab 109.8a 97.2b 0.04
3.5% Fat-corrected milk, lb/d 114.2 114.8 104.3 0.09
Solids-corrected milk, lb/d 104.3 105.4 95.7 0.09
Fat, % 3.88x 3.64y 3.79xy 0.08
True protein, % 2.90 2.92 2.97 0.52
Milk urea nitrogen, mg/dL 15.2a 12.7b 11.9b <0.01
Milk/DMI, lb/lb 1.92 2.02 1.87 0.18
Milk nitrogen efﬁciency, % 34.2b 37.6a 35.6ab 0.005
Serum NEFA, μEq/L (1-21 DIM) 452aby 577ax 431by 0.03
Serum BHBA, mg/dL (1-21 DIM) 9.3 8.8 7.8 0.15
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